Nagpal ; Giriraj's scientific contributions
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publication (1)
Breast cancer is one of the most common types of cancer among women globally, caused by mutations in the estrogen/progesterone receptors, and conventional treatment methods are commonly utilized. About 70–80 percent of individuals with the early-stage non-metastatic disease may be cured. Conventional treatment is far less than the optimal ratio, as...
Citations
... Various drug delivery systems have been developed to overcome the harmful side effects, drug loss and degradation, and poor bioavailability issues associated with drugs (Torchilin, 2001;Panyam & Labhasetwar, 2003). Surfactants, soluble polymers, microcapsules, cell-penetrating peptides, micelles, lipoproteins, liposomes, and microparticles made up of biodegradable natural or synthetic polymers are examples of some of the most commonly used drug carriers (Reddy & Swarnalatha, 2010;Tagde et al., 2022). Each nanocarrier has its own merits and demerits therefore, the choice of selection of nanocarrier depends on relevant considerations (Torchilin, 2001). ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/1097324805787648-1638634029721_Q64/Priti-Tagde.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/959318190989312-1605730688720_Q64/Agnieszka-Najda.jpg)
